9 completed, 2 unknown, 1 not yet recruiting, 1 terminated. 5 Phase 3, 3 Not applicable, 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 4, Unknown 1 |
| Not applicable | 3 | Completed 2, Terminated 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Thrombophlebitis: new trials by email Literature Review of Thrombophlebitis trials Research Report on Thrombophlebitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Implementing an Evidence-based, Standardized Care Bundle Targeting Register Nurses and Anaesthesiologists, to Enhance Patient Safety and Quality of Intravascular Access Devices Care Management - The Safe-IVADs Project. A Longitudinell Implementation Intervention With an Embedded Process Evaluation. The Safe IVADs project - Phlebitis, Thrombophlebitis | Not yet recruiting | Sahlgrenska University Hospital | 700 | 2026-07-20 | 2026-06-25 | |
| Comparison of Dwell Time of Open Versus Closed Type Peripheral Intravenous Cannula Closed-type peripheral cannula, Open type peripheral cannula - Thrombophlebitis | Not applicable | Completed | Post Graduate Institute of Medical Education and Research, Chandigarh | 100 | 2025-10-01 | 2026-02-18 |
| Diagnostic Performance of General Practitioners in Compression UltraSound Compression ultrasound - Deep Vein Thrombosis | Not applicable | Terminated | University Hospital, Caen | 15 | 2022-10-03 | 2024-09-20 |
| The Effectiveness of Topical Sesame Oil in Preventing Phlebitis at IV Cannula Sites in Adults Topical Sesame Oil, Liquid paraffin oil - Phlebitis, Thrombophlebitis | Not applicable | Completed | National Heart Centre Singapore | 263 | 2022-04-12 | 2024-02-21 |
| Comparative Study of the Hemorrhagic Risk in Patients Over 75 Years of Age Taking Enoxaparin Venous Thromboembolic Disease | Unknown | University Hospital, Strasbourg, France | 2000 | 2021-11-18 | 2021-12-09 | |
| Efficacy and Tolerability of Hirudoid Cream in Prophylaxis and Treatment Infusion Phlebitis Hirudoid cream 0.3 % Mucopolysaccharide polysulfate, Placebo cream without active substance - Thrombophlebitis, Phlebitis | Phase 3 | Completed | Medinova AG | 144 | 2015-05-01 | 2017-12-14 |
| Safety and Efficacy of Oral Versus Intravenous Amiodarone in the Treatment of AF Amiodarone - Atrial Fibrillation | Phase 3 | Unknown | Western Galilee Hospital-Nahariya | 104 | 2013-05-01 | 2013-03-25 |
| Efficacy of Low Molecular Weight Heparin in Superficial Vein Thrombosis Dalteparin - Superficial Thrombophlebitis | Phase 4 | Completed | University Medical Centre Ljubljana | 68 | 2010-12-01 | 2018-05-04 |
| Different Doses and Duration of Low Molecular Weight Heparin (Parnaparin)in Superficial Vein Thrombosis LMWH parnaparin subcutaneously - Thrombophlebitis | Phase 3 | Completed | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 664 | 2006-08-01 | 2021-03-19 |
| POST (Prospective Observational Superfial Thrombophlebitis) compression ultrasonography at 3 months - Thrombophlebitis | Completed | Centre Hospitalier Universitaire de Saint Etienne | 844 | 2005-03-01 | 2009-01-13 | |
| Treatment for Blood Clots in the Veins of the Legs Recombinant Tissue Plasminogen Activator, Heparin, Warfarin - Embolism, Thrombophlebitis | Phase 1 | Completed | National Institutes of Health Clinical Center (CC) | 20 | 1998-02-01 | 2008-03-04 |
| Phlogenzym® in Patients With Acute Thrombophlebitis - Efficacy and Tolerance Phlogenzym, Placebo - Thrombophlebitis Leg | Phase 3 | Completed | Mucos Pharma GmbH & Co. KG | 100 | 1996-09-01 | 2018-03-19 |
| Boston Area Anticoagulation Trial for Atrial Fibrillation (BAATAF) warfarin - Arrhythmia, Atrial Fibrillation | Phase 3 | Completed | Massachusetts General Hospital | 1985-07-01 | 2014-04-10 |
Phlebitis (4) · Venous Thrombosis (3) · Atrial Fibrillation (2) · Arrhythmias, Cardiac (1) · Cardiovascular Diseases (1) · Cerebrovascular Disorders (1) · Embolism (1) · Heart Diseases (1) · Intracranial Embolism and Thrombosis (1) · Pulmonary Embolism (1) · Stroke (1)
Embolism and Thrombosis (13) · Peripheral Vascular Diseases (13) · Thrombosis (13) · Vascular Diseases (13) · Vasculitis (13) · Cardiovascular Diseases (12) · Venous Thrombosis (10) · Phlebitis (9) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Arrhythmias, Cardiac (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Embolism (1) · Heart Diseases (1)
Warfarin (2) · Amiodarone (1) · Dalteparin (1) · Heparin (1) · Mineral Oil (1) · Phlogenzym (1) · Sesame Oil (1) · Tissue Plasminogen Activator (1) · Wobenzym (1) · mucopolysaccharide polysulfate (1)
Centre Hospitalier Universitaire de Saint Etienne (1) · IRCCS Azienda Ospedaliero-Universitaria di Bologna (1) · Massachusetts General Hospital (1) · Medinova AG (1) · Mucos Pharma GmbH & Co. KG (1) · National Heart Centre Singapore (1) · National Institutes of Health Clinical Center (CC) (1) · Post Graduate Institute of Medical Education and Research, Chandigarh (1) · Sahlgrenska University Hospital (1) · University Hospital, Caen (1) · University Hospital, Strasbourg, France (1) · University Medical Centre Ljubljana (1) · Western Galilee Hospital-Nahariya (1)
France (3) · Italy (2) · India (1) · Israel (1) · Singapore (1) · Slovenia (1) · Sweden (1) · Thailand (1) · United States (1)
Atar Shaul, MD (1) · Benilde Cosmi, MD PhD (1) · Gerhard Stauder, Dr (1) · Gualtiero Palareti, MD (1) · Inderpaul S Sehgal, DM (1) · Jasmine Tan (1) · Lilach Shema-didi, PhD (1) · Marcel Baumueller, MD (1) · Nicola Makhoul, MD (1) · Pavel Poredos, M.D., Ph.D. (1)
PMID 20157136, PMID 22429908, PMID 24807875
R01HL033233 (1)